General MedicationsINJECTIONGeneric
ZANOSAR
STREPTOZOCIN
Standard Dose
1GM/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ZANOSAR is listed in Drugs@FDA under application 050577 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient STREPTOZOCIN Form and strength INJECTABLE;INJECTION - 1GM/VIAL Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2016-11-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZANOSAR is listed in Drugs@FDA under application 050577 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient STREPTOZOCIN Form and strength INJECTABLE;INJECTION - 1GM/VIAL Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2016-11-14 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.